Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2021

Sep 23, 2021

33298_dirs_2021-09-23_1c107397-8fda-4de3-9c6a-2a7ca8831913.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-09-21

Reporting Person: DiTrolio Joseph (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-21 Restricted Stock Unit $ A 8000 Acquired Common Stock, par value $0.01 (8000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.01 20500 Direct

Footnotes

F1: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022.